State of Tennessee, Department of Treasury
AVTX icon

State of Tennessee, Department of Treasury’s Avalo Therapeutics AVTX Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9
Closed -$64K – 1585
2020
Q1 		$64K Buy
+9
New +$95.2K ﹤0.01% 1527

Other funds holding AVTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

State of Tennessee, Department of Treasury's AVTX Position: Q2 2020 in Review

State of Tennessee, Department of Treasury sold out of Avalo Therapeutics (AVTX) in Q2 2020, closing a stake of 9 shares — an estimated $64K sold.

State of Tennessee, Department of Treasury first reported a position in AVTX in Q1 2020 and held it in 1 quarter. The position peaked at $64K in Q1 2020. 55 funds tracked by Wall St. Rank hold AVTX as of Q2 2020.

  • State of Tennessee, Department of Treasury reported no remaining Avalo Therapeutics position as of Q2 2020 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 9 Avalo Therapeutics shares in Q2 2020, an estimated $64K.
  • State of Tennessee, Department of Treasury first reported a position in Avalo Therapeutics in Q1 2020 and held it in 1 quarter.
  • State of Tennessee, Department of Treasury's Avalo Therapeutics position peaked at $64K in Q1 2020.
  • 55 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q2 2020.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2020, filed 13 Aug 2020.